UPDATE : Friday, September 20, 2019
상단여백
‘Paternity testing’ would have prevented Invossa debacle
Kolon Life Science’s mislabeling one of the ingredients of Invossa-K, gene ...
by Jeong Sae-im  |  2019-04-02 15:27
라인
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’
MSD Korea’s Self-Assurance program initially aimed to ensure legitimacy, tr...
by Jeong Sae-im  |  2019-04-02 14:45
라인
Kolon apologizes for ‘mislabeled’ ingredient in Invossa
Kolon Life Science apologized Monday for “mislabeling” one of its key compo...
by Lee Han-soo  |  2019-04-01 17:35
라인
ST Pharm unveils pre-clinical trial results for HIV treatment
ST Pharm said Monday that it has presented the pre-clinical trial results f...
by Lee Han-soo  |  2019-04-01 15:39
라인
Argatroban raises bleeding risk in pregnant women
The Korean regulator would add a precaution label to argatroban, a treatmen...
by Lee Hye-seon  |  2019-04-01 15:29
라인
Hanmi launches seborrheic dermatitis treatment
Hanmi Pharmaceutical said Monday that it has launched Dupien, a seborrheic ...
by Lee Han-soo  |  2019-04-01 14:24
라인
[Special] Why doctors got upset with MSD Korea’s monitoring program
MSD Korea said it was running the Self-Assurance program to ensure legitima...
by Jeong Sae-im  |  2019-04-01 14:22
라인
Astellas Korea names Masujima Keita as new CEO
Astellas Korea said Thursday it appointed Masujima Keita as its new chief e...
by Lee Han-soo  |  2019-04-01 11:02
라인
Bayer reports 8th-consecutive-year growth in Asia-Pacific
Bayer Korea said Friday that 2018 was another year of robust growth for its...
by Lee Han-soo  |  2019-04-01 11:02
라인
LG Chem, Sprint to co-develop NASH treatment
LG Chem said Friday that it has signed a contract with Sprint Bioscience to...
by Lee Han-soo  |  2019-04-01 11:01
라인
‘Expanded reimbursement for Prolia to give more options to osteoporosis patients’
Amgen Korea said Friday Prolia (ingredient: denosumab), a biological agent ...
by Lee Han-soo  |  2019-03-29 18:32
라인
Phase-3 trials of Huntington’s chorea treatment approved
The government has granted the nod to go ahead with phase-3 trials on deute...
by Lee Hye-seon  |  2019-03-29 17:24
라인
Il-yang to research Parkinson’s disease in Europe
Il-yang Pharmaceutical said Wednesday that it plans to start full-fledged c...
by Lee Han-soo  |  2019-03-28 16:28
라인
Allergan to resume marketing of macular edema treatment
Allergan Korea said Tuesday that it has started re-marketing Ozurdex (ingre...
by Lee Han-soo  |  2019-03-27 16:55
라인
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe
JW Life Science said it has become Asia’s first pharmaceutical firm to sell...
by Jeong Sae-im  |  2019-03-27 16:16
라인
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment
CrystalGenomics said Tuesday that Aptose Bioscience, its U.S. partner, has ...
by Lee Han-soo  |  2019-03-27 15:58
라인
‘Remimazolam has fewer side effects than propofol’
Hana Pharma said its new general anesthetic drug remimazolam demonstrated e...
by Jeong Sae-im  |  2019-03-27 15:05
라인
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has published a phase 3 clinical trial f...
by Lee Han-soo  |  2019-03-27 14:52
라인
AstraZeneca to launch Imfinzi in Korea next month
AstraZeneca said it would launch Imfinzi (ingredient: durvalumab), an immun...
by Lee Han-soo  |  2019-03-27 14:52
라인
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis
Hanlim Pharm said it would test HL301, a drug candidate for bronchitis, to ...
by Lee Hye-seon  |  2019-03-26 15:57
여백
여백
여백
Back to Top